Dual Diagnosis

26 registered clinical trials studyying Dual Diagnosis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Psychosocial Factors in Dual Diagnosis in a General Hospital NCT07443033	Hospital Virgen del Puerto	—
Not Yet Recruiting	VR Based Therapy to Treat Anxiety in Dual Diagnosis NCT06315660	Mental Health Centre Sct. Hans	N/A
Recruiting	Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing NCT06311838	Ohio State University	N/A
Recruiting	CRP and S&A for Inpatient Veterans NCT05054738	VA Office of Research and Development	N/A
Active Not Recruiting	Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use NCT04105231	Lone Baandrup	Phase 2
Completed	Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services NCT02233738	VA Office of Research and Development	N/A
Unknown	Trial of Supportive Text Messages for Patients With Alcohol Use Disorder and a Co-morbid Depression NCT02404662	St Patrick's Hospital, Ireland	N/A
Completed	A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users NCT02192931	Perry Renshaw	Phase 4
Completed	Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? NCT01964404	Dartmouth-Hitchcock Medical Center	Phase 1
Completed	Ondansetron for Bipolar Disorder and Alcohol Use Disorders NCT02082678	University of Texas Southwestern Medical Center	Phase 4
Completed	Clozapine for Cannabis Use in Schizophrenia NCT01639872	Dartmouth-Hitchcock Medical Center	Phase 4
Completed	Creatine as a Treatment Option for Depression in Methamphetamine Using Females NCT01514630	Perry Renshaw	Phase 4
Terminated	Open-Label Creatine Study for Female Meth Users NCT02189915	Perry Renshaw	N/A
Completed	Risperidone and Desipramine in Alcohol Use and Schizophrenia NCT01411085	Dartmouth-Hitchcock Medical Center	Phase 2
Completed	Benefits Management for People With Psychiatric Disabilities NCT01329393	Yale University	Phase 1
Completed	Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans NCT00706901	VA Office of Research and Development	N/A
Completed	Abstinence-Linked Money Management Multisite NCT01327586	Yale University	Phase 2
Completed	Cannabis and Schizophrenia: Self-Medication and Agonist Treatment NCT00946348	Dartmouth-Hitchcock Medical Center	Phase 1
Completed	Ostrobothnia Depression Study (ODS). A Naturalistic Follow-up Study on Depression and Related Substance Use Di NCT02520271	Seinajoki Central Hospital	N/A
Completed	Dual-Diagnosis and Compulsory Treatment NCT00970372	Sorlandet Hospital HF	—
Completed	Dual Diagnosis Self-Help Referral NCT00286728	VA Office of Research and Development	N/A
Completed	Effectiveness of Self-Help for Dually-Diagnosed Persons - 1 NCT00218582	National Institute on Drug Abuse (NIDA)	Phase 1 / Phase 2
Completed	Effectiveness of Advisor-Teller Money Manager NCT00105768	US Department of Veterans Affairs	Phase 1 / Phase 2
Completed	Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual NCT00498550	Dartmouth-Hitchcock Medical Center	Phase 4
Terminated	Alcoholism and Schizophrenia: Effects of Clozapine NCT00169026	Dartmouth-Hitchcock Medical Center	Phase 4
Completed	Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment NCT00012727	US Department of Veterans Affairs	Phase 2